Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00229697
Status:
COMPLETED
Last Update Posted:
2015-10-05
First Post:
2005-09-28
Brief Title:
Phase II Metastatic ERPgR Nolvadex - Iressa Study
Sponsor:
Organization:
AstraZeneca